國家圖書館典藏電子全文

1

~Don t be afraid to be weak;don t be proud to be strong.~ ~Don t be afraid to be weak;don t be proud to be strong.~ 87 2

Dehumanize 87 88 Correctional system 1995 30 Cronbach s alpha expert validity Cluster random sampling 203 3 200 Fre-quency distribution Chi-square Oneway ANOVA Pearson product-moment correlation coefficient 3

36 31 40 4

5

6

7

8

Team work Dehumanize 1995 1885 Proceeding of the National Conference of Charities and Correction Skidmore/Thackeray2002 Drug abuser treatment center Correctional system 1995 Substance abuse 2003 9

1961 1971 1988 1990 2001 44-69 1.17 70-79 4.48 80-83 31.66 --- 80 40 30 80 70 8 44 79 80 2000 60 2000 87 87 10

28 29 17 16 88 6 92 4 16 87 5 91 59,616 25,410 42.6 34,206 57.4 88 89 91 58 42 62,682 49,943 12,739 91 32 89 22 10 87 135 91 197 92 11

12

13 87 Sherry CormierBill Cormier1998 2000

14

15

Drugabuse National Commission on Marijuana and Drug Abuse 1 Nonmedical purpose 2 Prone to excess 3 Habit forming 4 5 To get high 1984 American Psychiatric Association DSM- Drug addiction Drug dependencedsm- 1980 Substance use disorderdsm- DSM- Substance usedisorder Substance dependence Sub -stance abuse 16

17 1991 2001 Physical psychological dependence Tolerance Withdrawal symptom or abstinence syndrome

WHO1964 1981 Dependence Tolerance Habituation Prochaska, Diclemente Norcross 1992 A spiral model of the stages of change 2-1 18

2-1 A spiral model of the stages of change 1700 (Petersen, T.McBride,A.2002) McCaghy1980 Disease-concept Reed1990 Petersen,T.McBride,A.2002 1.Age 40 15-16 45 15 31 2. Ethnicity 19

3. Social class 4. The impact of peers and family Wells and Rankin1991 5. Availability and accessibility 6. Culture and norms 1980s 1990s 7. Substances are enjoyable 1. 2. 3. 2003 1. 2. 3. 4. 20

5. 2001 1992 1. 1 2 3 4 2. 1 ------ 21

2 1 2 3 4 1 2 3. 22

Hepworth,D.H.,Rooney,R.H.Larsen,J.A.1997 1999 Cancrini et al.,1988 1990 (Petersen,T.McBride, A.2002) 2003 1. 2. 3. 4. 23

1. 1998 24 45 2001 2002 87 24

2. 1992 1992 1993 12 20 537 524 2002 25

62.7 90 12 91 1 (Peter- sen,t.mcbri-de,a.2002) 1. The moral model 2. Biological explanations 3. Neurones and neurotransmitters 4. Heredity and genetics 5. Personality 6. Psychological explanations 26

WHO1964 1. Narcotics 2. 3. LSD 4. 2001 1. Narcotics 1 Opium Codeine Thebaine Morphine 2 Heroin 3 Methadone, Meperidine, Pentazocine 2. Central nervous system depressants Choral Hydrate Barbiturates Tranquilizes 3. Central nervous system stimulants Amphetamines Cocaine 4. Hallucinoogens Psychedelics LSD MescalineMDAPCP 5. Cannabinoids Marijuana Hashish oil 1988 12 29 Narcotic drugs Psycho-tropic substance 1. 27

28 2. 3. LSD PCP 1. Narcotics methadone Pentazocine 1 Poppy 1 Opium2 Morphine3 Codeine4 Heroin 1874 1897 Dresper Bayer 2 Cocaine 3 Cannabis 1 Mari- huana 2 Hashish

4 1 Methadone 2 Pentazocine 2. Dangerous drugs Convention On Psychotropic Substan- ces 1 Stimulants Amphe- tamine 2 Depressants Norminox Ssseconal 3 Hallucinogens LSDLysergic acid diethylamide 35 8 16 29

( ) 50 60 70 79 FM2 MDMA Ketamine 2003 Common substances of abuse 30

1. 1. Opium Morphine Heroin 2. Pentazocine Methadone Pethidine Codeine -- Buprenorphin e Tramadol 2. ------- Secobarbital Barbiturates Amobarbital Methaqualone ---------- Triazolam Flunitrazepam Diazepam Alprazolam Benzodiazepines 31

3. GHB Ketamine K K 32

33 4. Cocaine Amphetamine Methamphetamine methylenedioxy-m ethamphetamine MDMA 1. 2. 3.

Cannabis Marijuana Hemp 5. Lysergide ELLISA LSD Acid Phencyclidine Love boat (PCP) 2000 1. Amphetmaines 1 1887 30 48-72 34

2 0.1 5 5 10 3 4 2-3 2. (Cocaine) 1 Erythroxylum Crack 2 0.2 5 10 3 35

3-4 1. 1 0.03 0.05 0.05-0.1 0.1-0.15 0.2-0.3 0.4 0.5 ---- ---- ---- ----- ----- ----- --- ---- 0.03 0.07---0.1 2 2. 36

1 Glue 2 3 3. 1 Secomal 4 Amytal 8 Norminox 4 2 3 3. 1 2 4. 1 Marijuana 2 LSD 3 Phencyclidine 37

Farley,O.W.Smith L.L.Boyle S.W.2000 correctional system 1995 2001 Farley,O.W. Smith L.L.Boyle S.W.2000 93 1 9 38

1997 Lowinson JH. Ruiz P, Millman RB, Langrod JG(eds):Substance Abuse A Comprehensive Textbook.2 nd Ed. Baltimore, Williams & Wilkins,1992,P913 1997 1. 2. 39

40 3. 1997 strengths perspec-tive 2004 approach-avoidance conflict 2002 C.E.Faupel C.B.Klockars1987

Faupel Klockars 2002 2-2 Farley,O.W.Smith L.L.Boyle S.W.2000 transinstitutionalization 2000 2000 83 12 ---- 10 1990 41

40 2001 82 50 83 34 --- 1996 1. 2. 3. 1. 2. 42

3. 4. 1. 2. 1. 2. 3. 1 2 4. 1 2 5. 1 2 1. 1 43

2 2. 1 Methadone Metha- done 2 1964 1973 7 3 1 2 3 4 3. 1 2 5 7 3 4 44

45

Kendall. P. C. & Hammen C.1998 40 1990 90 Berthold1989 1. Spiritual causes 2. Material causes 1990 46

1930 1950. PerlmanHelen Harris ego functions social task 1995 4Ps Person Problem Place Process 1995 4Ps 47

1987 1. 2. Significance others 3. Give-and-take 1. The caseworker-client relationship 2. Acceptance Expectation Support Stimulation 3. 1. Diagnosis 2. 3. 4. 48

1. treatment 2. (1) (2) 3. (1) (2) (3) (4) 49

4Ps Place 1999 1990 1. 2. learning set D Zurilla Goldfried1971Urban Ford1971Eisenberg Delaney1977Carkhuff Anthony 1979Kanfer Busemeyer1982Egan197519821986A Yates1986 Egan1982 Roger, Carkhuff Krumboltz Egan 50

Carkhuff Carkhuff Egan Carkhuff Carkhuff Involvement Exploration Understanding Action Egan cognition cognitive theory information-processing psychology information-processing psychology information-processing theory 2002 2002 51

learned helplessness Burrhus B. Skinner 2002 2002 problem solving 2002 cognitive style cognitive learning style D Zurilla Goldsfried(1971) 1990 Dixon Glover person-centered counseling 1. 2. 52

53 3. 4. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) Gestalt therapy 1. 2. (1) (2) (3) 3. (1) (2) (3) (4) (5)

(6) (7) (8) 4. behavioral counseling 1. (1) (2) (3) 2. Krumboltz(1966) (1) (2) (3) 3. 4. --- cognitive-behavioral counseling 1. 2. (1) (2) 54

----- (3) ----- (4) (5) (6) ----- (7) ----- (8) ----- (9) (10) ------ 3. 4. ----- 55

Wechsler 1958 Helga A.H.Rowe.1985 28 56

1998 1. 2. 3. 4. 5. 6. 1. 2. 1. 57

2. 3. 4. 5. 6. 1. 1 2 3 4 5 2. 3. 58

4. 5. 6. 59

60

1. 2. 3. 4. 5. 6. 1. 2. 3. 1. 2. 1. 2. 3. 4. 5. 6. 7. 8. 9. 61

1. 2. 62

1950 Perlman,Helen Harris 1995 87 5 20 Ego functions Social task 1995 63

1. 2.. 3. 18 64

Cluster random sampling 1. 2. 1998 Cluster 2003 6 100 140 1200 1600 91 18 24 24 30 30 40 40 4321 4321 6 1 30 Cluster random sampling 3 203 3 200 65

1993 87 1999 Likert Scale Summated Voting Scale R. Likert 1932 4 6 2000 4 1~4 66

Likert Likert Likert Likert Likert 2000 92 11 30 Cronbach s alpha 2.5 1.8 3.2 0.72 1.01 Cronbach s alpha 0.8952 0.7 Cronbach s alpha 0.3393 Cronbach s alpha 0.75630.75420.8459 0.8809 0.7 Cronbach s alpha 0.3393 3 4 5 4 5 expert validity 0.3 67

0.472 0.698 0.430 0.446 0.430 0.746 68

1011131517 Frequency distribution Nominal scale Chi-square Nonparametric statistical test Nominal scale Oneway ANOVA 69

Nominal scale Interval scale Pearson product-moment correlation coefficient Correlation co-efficient 2000 70

203 200 203 71

4.1-1 36 36.48 31 40 41.5 21 50 91 36 18 60 4.1-1 40 22 72

73 51.5 25.0 19.0 4.1-1 41.5 53.5 4.1-1 45.0 87.5 26.0 23.0 11.0 pub24

4-1.1 N200 19 ~20 42.0 21 ~30 4824.0 31 ~40 41 ~50 50 ~60 8341.5 5125.5 84.0 63.0 10.5 136.5 2512.5 52.5 52.5 8040.0 5929.5 115.5 10.5 10351.5 5025.0 63.0 31.5 3819.0 4.1-1 N200 8341.5 84.0 126.0 178.5 74

4623.0 3015.0 21.0 21.0 2512.5 10753.5 63.0 3015.0 73.5 136.5 42.0 84.0 9045.0 4020.0 31.5 2512.5 21.0 157.5 2010.0 52.5 168.0 2211.0 4623.0 5226.0 115.5 10.5 126.0 2914.5 115.5 1-3 52.5 3-6 3115.5 6-9 5829.0 9-12 9547.5 105.0 10.5 16482.0 2613.0 105.0 4.1-2 47.5 79.0 65.8 16.8 10.0 75

76 6.8 4.1-3 145 37 26 21 97 61 32 30 85 62 42 37 125 105 65 49 4.1-2 3718.5 ~ 3115.5 ~ 115.5

77 ~ 147.0 ~ 52.5 ~ 73.5 9547.5 15879.0 2814.0 52.5 10.5 10.5 52.5 12565.8 3216.8 1910.0 136.8 10.5 105.0 4.1-3 N200 173 77 3 2

37 145 18 26 21 10 4 7 12 30 22 61 32 18 97 5 26 62 37 24 21 85 10 7 42 25 105 23 28 25 125 29 65 49 4.1-4 51.5 22.5 40.0 4.1-4 78

/ 1( 0.5) 7( 3.5) 4(2.0) 2(1.0) 14( 7.0) 5(2.5) 6(3.0) 1( 0.5) 3(1.5) 1(0.5) 1( 0.5) 2(1.0) 2(1.0) 45(22.5) 19(9.5) 3(1.5) 2(1.0) 11(5.5) 29(14.5) 14(7.0) 3(1.5) 13(6.5) 5( 2.5) 3(1.5) 3(1.5) 1( 0.5) 13( 6.5) 25(12.5) 5( 2.5) 5( 2.5) 80(40.0) 59(29.5) 11( 5.5) 1( 0.5) 1(0.5) 103(51.5) 50(25.5) 6(3.0) 3(1.5) 38(19.0) 200(100) 4.1-5 80.2 36.5 4.1-5 / 72(36.5) 10(5.1) 3(1.5) 1(0.5) 1(0.5) 2(1.0) 32(16.2) 8(4.1) 2( 1.0) 1(0.5) 21(10.7) 3(1.5) 1(0.5) 2( 1.0) 11( 5.6) 2(1.0) 2(1.0) 16( 8.1) 3(1.5) 2( 1.0) 1(0.5) 1(0.5) 89(45.2) 40(20.3) 3( 1.5) 25(12.7) 2( 1.0) 15( 7.6) 19( 9.6) 42.0 3 158(80.2) 28(14.2) 5 (2.5) 1(0.5) 1(0.5) 4(2.0) 197(100) 4.2-1 79

4.2-1 / F P 13.00 9 100.937 12.617 2.965.04 17.00 188 799.936 4.255 16.72 196 900.8773 18.40 16.60 16.61 17.27 19.00 13.00 13.00 8 50.979 6.372.976.456 15.00 189 1233.728 6.528 14.76 197 1284.707 16.00 14.40 14.85 15.28 16.73 14.00 13.00 8 55.663 6.958 1.391.203 13.92 190 950.236 5.001 14.68 198 1005.899 16.40 14.61 14.93 16.09 15.00 13.00 P<0.05 P<0.01 80 P<0.001 4.2-2

4.2-2 / F P 17.45 6 68.253 11.376 2.584.02 16.50 188 827.726 4.403 16.64 194 895.979 16.63 17.22 15.80 17.50 16.99 15.65 6 109.054 18.176 3.033.007 14.75 189 1132.757 5.993 14.94 195 1241.811 15.48 13.57 16.00 15.13 19.00 15.22 6 64.624 10.771 2.226.042 15.63 190 919.254 4.838 14.83 196 983.878 14.18 14.72 13.77 16.50 14.80 P<0.05 P<0.01 P<0.001 4.3-1 81

4.3-1 / F P 13.00 8 100.937 12.617 2.965.004 17.00 188 799.936 4.255 ()16.72 196 900.873 ()18.40 16.60 16.61 ()17.27 ()19.00 13.00 15.00 8 178.953 22.369 3.173.002 13.08 189 1332.319 7.049 ()15.12 197 1511.273 ()17.40 13.00 15.01 ()15.91 ()17.00 13.00 P<0.05 P<0.01 P<0.001 4.3-2 82

4.3-2 / F P 16.96 7 58.873 8.410 1.898.072 17.25 188 833.107 4.431 16.67 195 891.980 16.24 20.00 18.07 16.42 17.50 15.46 7 112.754 16.108 2.177.038 16.10 189 1398.444 7.399 16.00 196 1511.198 13.92 17.00 15.53 14.21 14.00 P<0.05 P<0.01 P<0.001 83

4.4-1 4.4-1.463.465 P.000 P.000.513.502 P.000 P.000.463.494 P.000 P.000 P<0.05 P<0.01 P<0.001 4.4-2 84

4.4-2.320.308.214.314.253 P.000 P.000 P.002 P.000 P.000.415.318.281.312.291 P.000 P.000 P.000 P.000 P.000.301.318.303.306.297 P.000 P.000 P.000 P.000 P.000.185.293.222.144.224 P.009 P.000P.002 P.42 P.001.252.315.319.151.267 P.000 P.000P.000 P.033 P<0.05 P<0.01 P<0.001 P.000 4.4-3 85

4.4-3.419.313.364.335.369 86 P.000 P.000 P.002 P.000 P.000.362.401.427.307.404 P.000 P.000P.000 P.000 P.000.386.408.420.327.379 P.000 P.000 P.000 P.000 P.000.241.301.314.221.225 P.000 P.000 P.000 P.000 P.000.361.449.443.330.352 P.000 P.000 P.000 P.000 P.000 P<0.05 P<0.01 P<0.001 4.4-4 4.4-4.215.378.398.276.260 P.002 P.000 P.000 P.000 P.000.177.263.219.269.202 P.012 P.000 P.002 P.000 P.004.302.337.365.320.310 P.000 P.000 P.000 P.000 P.000.384.461.492.462.505 P.000 P.000 P.000 P.000 P.000.415.530.512.513.553 P<0.05 P.000 P.000 P.000 P.000 P.000 P<0.01 P<0.001 4.4-5 4.4-5.264.294.297.280.283

P.000 P.000 P.002 P.000 P.000.338.350.308.308.348 P.000 P.000 P.000 P.000 P.000.140.242.281.187.254 P.048 P.001 P.000 P.008 P.000.224.206.218.153.222 P.001 P.003 P.002 P.31 P.002.097.206.203.184.158 P.171 P.003 P.004 P.009 P.025 P<0.05 P<0.01 P<0.001 4.4-6 4.4-6.550.446.362.364.410 P.000 P.000 P.000 P.000 P.000.346.366.206.334.285 P.000 P.000 P.004P.000 P.000.291.387.304.305.309 P.000 P.000 P.000P.000 P.000.234.119.196.136.170 P.001 P.094 P.005 P.055 P.016.268.376.332.220.307 P.000 P.000 P.000P.002 P<0.05 P<0.01 P<0.001 P.000 4.4-7 4.4-7.106.222.137.150.154 87

P.134 P.002 P.053 P.034 P.030.168.315.266.250.243 P.018 P.000 P.000 P.000P.001.288.345.274.326.295 P.000 P.000 P.000 P.000 P.000.302.513.353.330.336 P.000 P.000 P.000 P.000 P.000.233.383.397.427.430 P.001 P.000 P.000 P.000 P.000 P<0.05 P<0.01 P<0.001 1 3 1 88

3 1 4 4 1 8 25 8 1 3 6 1 1 2 1 1 3 2 2 2 2 2 2 1 1 5 1 1 2 1 1 3300 14 3 1 1 89

87 90

2000 1. 2. 1. 91

2. 92

1 2 3 4 5 31 40 40 22 62 93

65.8 16.8 93 1 6 1800 500 Farley,O.W.Smith L.L. Boyle S.W.2000 94

45 20 12.5 77.5 7.5 1.0 18 60 95

96

transinstitutionalization 2000 97

98

1. 2. 99

100

93 1 6 Cronbach s alpha 0.3393 2000 101

2000 --- Interivewing strategies for helpersfundamental skills and cognitive behavioral interventionns,4 th ed.bill Cormier,Sherry Cormier 2003 285-287. 102

2002 2001 1992 33 1995 1995 1998 2002 2000 SPSS 1-12,1-20,2-15~2-16,3-4~3-19. 2000 1,63-112. 1991,62. 2001 2002 3,4,7,8. 2002 1984 1996 2000 --- 1999 Direct social work practicetheory and skill,5 th ed.dean H. Hepworth,Ronald H.Rooney,Jo Ann Larsen 2003 1990 ----- 2000 1993 103

2002 39,277-290. 1987 1993 1990 2001 2001 2000 2002 2002 1996 1999 2002 1998 316. Dakof,G.A.,Quille, T.J.,Tejeda,M.J.,Alberga,L.R.,Band stra,e.(2003). Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment. Journal of Consulting and Clinical Psychology, 71(4), 764-772. Dixon, D. N.,Glover, J.A.(1984).Counseling: a problem-solving app- roach. New York: John Wiley & Sons.35-61. Dugan,M.A.(1996).The role of resilience and protective factors in predict- ing alcohol, tobacco and other drug abuse in youth.(doctoral Dissertation, Claremont Graduate University,1996).(AAT 9707501 UMI Pro-Quest Digital Dissertations-Full CitationAbstract). Farley,O.W.Smith L.L.Boyle S.W.2000.Charpter17Drug Abuse and Social Work. Introduction to Social Work. (Skidmore,R.A.Thacke- ray M.G. ), Eighth Edition. United States of America. Helga A.H.Rowe.(1985).Problem solving and intelligence.australian coun- cil educational research.lawrence erlbaum associates,hillsdale,new Jersey,London.1,3,4,8,15 104

Kendall,P.C.&Hammen,C.(1998).Abnormal psychology understanding human problems.printed in the U.S.A.by Houghton Mifflin Company.332. McDowell,D.M.Spitz,H.I.(1999).Substance abuse: from principles to practice.usa:brunner/mazel. Petersen,T.McBride,A.(2002).Working with substance misusers: a guide to theory and practice.usa and Canada.23-27,29,92. Skidmore,R.A.Thackeray M.G. 2000.Charpter17Drug Abuse and Social Work. Introduction to Social Work.United States of America. Steven, B.,Michelle, A. L.,Lisa A.O.(2003).Self-Reported psychiatric treatment needs among felony drug offenders. Journal of Contemporary Criminal Justice,19(1),9-29. William, R.M.,Carolina E.Y.,Tonigan J.S.(2003).Motivational interviewing in drug abuse services:a randomized trial. Journal of Consulting and Clinical Psychology,71(4),754-763. 105

106

107 1 2 3 4 5 6 7 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 1 23 4 5 6 7 1 2 3 4 56 7 8 9 1 2 3 4 5 1 2 3 4 5 6 1 2

108 3 4 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 1 2 3 4 5 6 7 8

109

110

111

112

113

1 2 ( ) ( ) ( ) ( ) 3 4 114

5 6 7 8 115

9 10 11 11-1 12 13 14 116

15 16 17 18 19 117

20 ( ) ( ) ( ) 20-1 118

21 ( ) 22 23 ( ) ( ) 23-1 23-2 ( ) 24 24-1 119

25 ( ) 26 27 ( ) () ( ) ( ) () 28 ( ) () 120

29 30 30-1 31 32 32-1 121

32-2 33 33-1 () () () () 34 35 122

( ) ( ) 36 1 (Acetorphine) 2 (Cocaine) 3 (Desomorphine) 4 (Dihydroetorphine) 5 (Etorphine) 6 (Heroin) 7 (Ketobemidone) 8 ( ) (Opium) 9 (Morphine) 1 (Acetyl alpha methylfentanyl) 2 (Acetyldihydrocodeine) 3 (Acetylmethadol) 4 (Alpha methyl fentanyl) 5 (Alpha methadol) 123

6 (Alpha methyl thiofentanyl) 7 (Alphaprodine) 8 (Alfentanyl) 9 (Allylprodine) 10 (Alphacetyl methadol) 11 (Alphameprodine) 12 (Amphetamine) 13 (Anileridine) 14 (Benzethidine) 15 (Benzylmorphine) 16 (Betacetylmethadol) 17 (Betahydroxyfentanyl) 18 (Betahydroxy 3methyl fentanyl) 19 (Betameprodine) 20 (Betamethadol) 21 (Betaprodine) 22 (Bezitramide) 23 (Brolamfetamine) 24 (Cannabis) ( ) 25 (Cannabis resin) 26 (Cannabis extracts) 27 (Cannabis tinctures) 28 (Carfentanyl) 29 (Cathinone) 30 (Clonitazene) 31 (Coca) 32 (Coca leaves) 33 (Codeine) 100 (100 ) 5.0 34 (Codeine methyl bromide) 35 N (Codeine N oxide) 36 (Codoxime) 124

37 (Concentrated Poppy straw) 38 (Cyprenorphine) 39 (Dexamphetamine) 40 (Dextromoramide) 41 (Dextropropoxyphene) 42 (Diampromide) 43 (Diethylthiambutene) 44 (DET) 45 (Difenoxin) 46 (Dihydrocodeine) 100 ( 100 ) 5.0 47 (Dihydromorphine) 48 (Dimenoxadol) 49 (Dimepheptanol) 50 (Dimethylthiambutene) 51 (DMT) 52 (Dioxaphetylbutyrate) 53 (Diphenoxylate) 54 (Dipipanone) 55 (DMA) 56 (1 2 ) (DMHP) 57 (DOET) 58 (DOMSTP) 59 (Drotebanol) 60 (Ecgonine) 61 (Ecgonine Derivatives) 62 (Ethylmethyl thiambutene) 63 (Ethylmorphine) 64 (Eticyclidine) 65 (Etonitazene) 66 (Etoxeridine) 67 (Fentanyl) 68 (Fenetylline) 125

69 (Furethidine) 70 (Hydromorphinol) 71 (Hydrocodone) 72 (Hydromorphone) 73 (Hydroxypethidine) 74 (Ibogaine) 75 (Isomethadone) 76 (Levamphetamine) 77 (Levomethorphan) 78 (Levomoramide) 79 (Levorphanol) 80 (Levophenacyl morphan) 81 (LSDLysergide) 82 (MDA) 83 3,4 ( ) MDMA dimethyl 3,4 (methylenedioxy) phenethy- lamine 84 (Mecloqualone) 85 (Mescaline) 86 (Metazocine) 87 (Methadone) 88 (Methadone intermediate) 89 (Methamphetamine) 90 (Methamphetamine Racemate) 91 (Methaqualone) 92 (4 methylaminorex) 93 (Methyldesorphine) 94 (Methyldihydromorphine) 95 (3 Methylfentanyl) 96 (3 Methylthio fentanyl) 97 (Metopon) 98 4,5 ( ) MMDA 2 methoxy methyl 4,5 (methy- lenedioxy) phenethylamine 126

99 (Moramide intermediate) 100 (Morphine methobromide) 101 (Morphine methylsulfonate) 102 (Morphine N oxide and its Derivatives) 103 MPPP1 methyl 4 phenyl 4 piperidinol propionate (ester) 104 (Myrophine) 105 (Nabilone) 106 (N ethyl amphetamine) 107 (N ethyl MDA) 108 (N ethyl 3 piper-idyl benzilate) 109 (N hydroxy MDA) 110 (N methyl 3 piper-idyl benzilate) 111 (Nicodicodine) 112 (Nicocodine) 113 (Nicomorphine) 114 (N N dimethyl amphetamine) 115 (Noracymethadol) 116 (Norcodeine) 117 (Norlevorphanol) 118 (Normethadone) 119 (Normorphine) 120 (Norpipanone) 121 (Opium Poppy) 122 ( ) (Oxycodone) 123 (Oxymorphone) 124 (Para fluoro fentanyl) 125 (Parahexyl) 126 (Phencyclidine) 127 (Pentazocine) 127

128 1 4 4 PEPAP,1 phenethyl 4 phenyl 4 piperidinol acetate (ester) 129 (Pethidine) 130 (Pethidine intermediate A) 131 (Pethidine intermediate B) 132 (Pethidine intermediate C) 133 (Peyote) 134 (Phenadoxone) 135 (Phenampromide) 136 (Phenazocine) 137 (Phenomorphan) 138 (Phenoperidine) 139 (Pholcodine) 140 (Piritramide) 141 (PMA) 142 (Poppy straw) 143 (Proheptazine) 144 (Properidine) 145 (Propiram) 146 (Psilocine) 147 (Psilocybine) 148 (Racemethorphan) 149 (Racemoramide) 150 (Racemorphan) 151 (Rolicyclidine) 152 (Sufentanil) 153 (TenocyclidineTCP) 154 1 1 (2 ) TCPY,1 1 (2 thienyl) 155 ( Tetrahydrocannabinol ) 10 ug/g (10ppm) 156 (Thebacon) 128

157 (Thebaine) 158 (Thiofentanyl) 159 (Tilidine) 160 (TMA) 161 (Trimeperidine) 162 (Morpheridine) 163 (Piminodine) 164 (Etryptamine) 165 (Levomethamphetamine) 166 (Methcathinone) 167 (Gammahydroxybutyrate) 1 (Amobarbital) 2 (Brotizolam) 3 (Buprenorphine) 4 (Butalbital) 5 (Cathine) 6 (Cyclobarbital) 7 (Glutethimide) 8 (Methylphenidate) 9 (Nalbuphine) 10 (Nalorphine) 11 (Pentobarbital) 12 (Phenmetrazine) 13 (Secobarbital) 14 (Tramadol) 15 ( ) (Triazolam) 16 (Codeine ) 100 (100 ) 1.0 5.0 17 (Flunitrazepam) 18 (Zipeprol) 129

19 Ketamine 20 (Dihydrocodeine) 100 (100 ) 1.0 5.0 1 (Allobarbital) 2 ( ) (Alprazolam) 3 (Amfepramone) 4 (Aminorex) 5 (Barbital) 6 (Benzfetamine) 7 ( ) (Bromazepam) 8 (Butobarbital) 9 ( ) (Camazepam) 10 ( ) (Chlordiazepoxide) 11 ( ) (Clobazam) 12 ( ) (Clonazepam) 13 ( ) (Clorazepate) 14 ( ) (Clotiazepam) 15 ( ) (Cloxazolam) 16 (Codeine) ( ) 100 1.0 17 ( ) (Delorazepam) 18 (Dextropropoxyphene Mix- ture Preparation) 19 ( ) (Diazepam) 20 ( ) (Estazolam) 21 ( ) (Ethchlorvynol) 22 ( ) (Ethinamate) 23 ( ) (Ethyl Loflazepate) 24 ( ) (Etilamfetamine) 25 ( ) (Fencamfamin) 130

26 ( ) (Fenproporex) 27 ( ) (Fludiazepam) 28 ( ) (Flurazepam) 29 ( ) (Halazepam) 30 ( ) (Haloxazolam) 31 ( ) (Ketazolam) 32 ( ) (Lefetamine) 33 ( ) (Loprazolam) 34 ( ) (Lorazepam) 35 ( ) (Lormetazepam) 36 () (Mazindol) 37 ( ) (Medazepam) 38 (Mefenorex) 39 ( ) (Meprobamate) 40 (Mesocarb) 41 (Methylphenobabital) 42 ( ) (Methyprylon) 43 ( ) (Midazolam) 44 ( ) (Nimetazepam) 45 ( ) (Nitrazepam) 46 ( ) (Nordazepam) 47 (Opium) 100 (100 ) 0.5 48 ( ) (Oxazepam) 49 ( ) (Oxazolam) 50 () (Pemoline) 51 ( ) (Phendimetrazine) 52 (Phenobarbital) 53 ( ) (Phentermine) 54 ( ) (Pinazepam) 55 ( ) (Pipradrol) 56 ( ) (Prazepam) 57 ( ) (Propylhexedrine) 131

58 ( ) (Pyrovalerone) 59 ( ) (Secbutabarbita1) 60 ( ) (Temazepam) 61 ( ) (Tetrazepam) 62 ( ) (Vinylbital) 63 (Zopiclone) 64 (Modafinil) 65 (Zolpidem) 66 ( ) 100 1.0 (Physician prescribes Dihydrocodeine oral liqu- id [including syrup] with dihydrocodeine content less than 1.0 gram per 100 milliliters) ( ) 1 (Ephedrine) 2 (Ergometrine) 3 (Ergotamine) 4 (Lysergic acid) 5 (Methylephedrine) 6 (Phenylpropanolamine) 7 (Pseudoephedrine) 132

1 ( ) 2 3 4 5 6 7 8 9 133

10 () () 11 11-1 12 134

13 14 15 16 17 18 () 19 () () 20 21 () () 22 23 24 25 135

( ) ( ) ( ) 26 ( ) ( ) 136

( ) 27 137

1 2 3 4 () () 5 () 6 138

() 7 8 () () () () () 9 10 11 12 139

13 () () 14 15 16 () 17 18 140

1 2 3 4 5 6 7 8 141

9 10 11 12 13 14 15 16 142

17 18 19 20 21 ( ) ( ) ( ( ) ) 143

144

( ) ( ) ( ) 145

146

147

148

149

150 1. 2. 3. 4. 5.

1. 2. 3. 4. 151